Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...

The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...

"If you think you've learned it all and you're going to open up the playbook and just impose it on the company, that's not ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

Engineer Leslie Holt led a group of students at the University of Connecticut as they created a tool that simulates finding a ...

Johnson & Johnson stock jumped Wednesday after the Dow health behemoth raised its guidance in the wake of a bullish second-quarter report.

What helps them do that? Three traits stand out: attention, authenticity and agility. Together, they form a simple framework ...